In a report released today, Matt Miksic from Barclays reiterated a Buy rating on Medtronic (MDT – Research Report), with a price target ...

In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report).

The hit to demand for spinal devices from deferred procedures pulled down revenue from the neuroscience unit in Q2 2022 ...

Many of the top large-cap device makers reported relatively rosy fourth-quarter earnings while issuing 2023 guidance that was above analyst expectations.

While companies haven’t disclosed the exact terms of the settlements, Medtronic has begun educating physicians about the shortcomings of its devices and providing QR codes on its devices that ...

Fortunately for Medtronic, they have dozens of prospects outside of their insulin pumps and a considerable moat in cardiac devices. Make no mistake about it, while Medtronic is a solid company ...

The Centers for Medicare & Medicaid Services granted transitional pass-through (TPT) payment status to Medtronic and Recor Medical for renal denervation devices to treat high blood pressure.

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves ...

Medtronic holds a dominant share in the market for pulse oximeters, Aboelata said. “Ultimately, we want the FDA to hold themselves and manufacturers accountable for ensuring the devices work for ...

However, to ensure uninterrupted inhibition of therapy, care must be exercised to maintain proper magnet positioning over the implanted device. St. Jude Medical and Medtronic were also asked about ...